This grant opportunity aims to support early-stage research for creating new malaria vaccines or treatments using monoclonal antibodies. It focuses on developing combination vaccines, vaccines that provide broad protection, and improving how these products are delivered and made. The overall goal is to increase the number of potential options for preventing malaria worldwide.

The NOSI aims to support early-phase translational research to develop new malaria vaccine candidates or monoclonal antibody-based interventions. This includes research on combination vaccine concepts, broadly protective vaccines, and improved administration and manufacturability of products. Th… Show More